FindTrial
Sign In

Study of 3 different dosages i.e Itraconazole 100mg vs 200mg vs 400mg or 5mg/kg whichever is lower in treatment of dermatophytosis (Ringworm)

Itraconazole in the treatment of dermatophytosis : A comparison of 3 different dose regimens: A triple arm randomized control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027063
Enrollment
126
Registered
2020-08-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Itraconazole: Itraconazole 100 mg/day for 30 days Control Intervention1: Itraconazole: Itraconazole 100 mg 2 CAP/day for 30 days Control Intervention2: Itraconazole: Itraconazole 100 mg

Sponsors

SOA university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All naive cases of dermatophytosis 2. Potassium hydroxide (KOH) positive cases 3. Treated cases but off treatment from topical/systemic antifungal for the last four weeks

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating females. 2. History of diabetes. 3. Immunosuppressed patients. 4. Patient on drugs that interfere with itraconazole metabolism 5. History of hepatic and renal impairment. 6. Cases of congestive heart failure.

Design outcomes

Primary

MeasureTime frame
KOH status Culture status Clinical clearanceTimepoint: Outcome will be assessed after completion of study in june 2021.—

Secondary

MeasureTime frame
Safety profileTimepoint: In terms of side effects of the drug at 4th week and 6th week—

Countries

India

Contacts

Public ContactABHISHEK C LACHURE

INSTITUTE OF MEDICAL SCIENCE and SUM HOSPITAL

bikashkar@soa.ac.in9937428181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026